Results of a study presented at EAN 2020 demonstrate that it is feasible to assign multiple sclerosis (MS) patients to 5 groups based on homogeneous disease characteristics.
News
News
Daily digests from key neurology conferences, written by on-site medical journalists.
Published: May 25, 2020